Home

ProQR Therapeutics NV (PRQR)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about ProQR Therapeutics NV (PRQR)

Go deeper and ask any question about PRQR

Company Performance

Current Price

as of Sep 13, 2024

$1.85

P/E Ratio

N/A

Market Cap

$151.11M

Description

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.

Metrics

Overview

  • HQLeiden, ZH
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerPRQR
  • Price$1.850.00%

Trading Information

  • Market Cap$151.11M
  • Float64.59%
  • Average Daily Volume (1m)102,303
  • Average Daily Volume (3m)110,206
  • EPS-$0.29

Company

  • Revenue$16.64M
  • Rev Growth (1yr)417.56%
  • Net Income-$2.90M
  • Gross Margin88.72%
  • EBITDA Margin-48.30%
  • EBITDA-$3.28M
  • EV$51.43M
  • EV/Revenue3.09
  • P/EN/A
  • P/S9.08
Documents